(Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks ...

The Fox News Lifestyle Newsletter brings you trending stories on family, travel, food, neighbors helping neighbors, pets, ...

Viking Therapeutics said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a ...

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

People whose diet contained fewer processed foods lost twice as much weight than people who ate more ultra-processed foods, a ...

Jelly Roll's Wife Shares Honest Thoughts on His Dramatic Weight-Loss Transformation originally appeared on Men's Fitness.

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

It’s not just above the waistline where the effects of Ozempic are taking place. Hush-hush conversations online have revealed ...

Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass. It’s crucial to do ...

The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the ...

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...